Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2005
10/06/2005WO2005075471A3 Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
10/06/2005WO2005046599A3 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222226 N-[3-(2-Aminoethyl)-4-(4-bromophenyl)thiazol-2(3H)-ylidene]aniline; antiinflammatory agents, antiallergens; inhibit infiltration of leukocytes such as eosinophils and lymphocytes; autoimmune diseases, asthma
10/06/2005US20050222224 p53 Inhibitors and therapeutic use of the same
10/06/2005US20050222223 And oxazole sulfonamides: 3-(2-{1-[(4-Chloro-benzenesulfonyl)-(2,5-difluoro-phenyl)-amino]-ethyl}-thiazol-5-yl)-propionic acid; Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis, cerebral amyloid angiopathy, prion-mediated disease, inclusion body myositis, stroke, multiple sclerosis
10/06/2005US20050222222 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
10/06/2005US20050222221 Cell differentiation, regeneration of pancreas epithelial cells to insulin producing beta cells; administering a dipeptidyl-peptidase activators
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222207 Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs
10/06/2005US20050222203 Nitrogen heterocycle biaryls for osteoporosis and other diseases
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222129 Non-imidazole heterocyclic compounds
10/06/2005US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides
10/06/2005US20050218532 higher reactivity with an electrophile; lithium chloride complexes; using organometallic R1(MgX).LiY, a fast exchange reaction occurs leading to Grignard reagents in high yields under mild conditions; ether solvent; phenyl-(4-cyanophenyl)methanol from benzaldehyde, 4-bromobenzonitrile and i-PrMgCl.LiCl
10/06/2005DE10361794B3 Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese Optically active heteroaromatic beta-hydroxy ester, and processes for their preparation and their use as intermediates in the total synthesis of epothilone-
10/06/2005CA2560128A1 Intermediates for the preparation of pramipexole
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/05/2005EP1582523A1 Method of preparing organomagnesium compounds
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581472A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005EP1581214A1 4,5-diarylthiazole derivatives as cb-1 ligands
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005CN1678596A Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678311A Aryl carbonyl derivatives as therapeutic agents
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951948 Method for synthesis of substituted azole libraries
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005CA2238275C Metalloproteinase inhibitors
09/2005
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090321A1 Process for purification of 2-chloro-5-chloromethyl -1,3-thiazole
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005090295A2 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
09/29/2005WO2005089755A1 Aqueous composition comprising thiazole derivative
09/29/2005WO2005070042A3 Novel chemical compounds
09/29/2005WO2004084843A3 Inhibitors of cathepsin s
09/29/2005US20050215795 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
09/29/2005US20050215642 Aromatic guanidine compound; antitumor agents; anticancer agents; for the treatment of breast cancer
09/29/2005US20050215605 Preterm labor, premature birth, dysmenorrhea; inhibitors of the prostaglandin F2 alpha receptor; e.g. 3-([1,1'-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559047A1 N-substituted benzene sulfonamides
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578737A1 Substituted heterocyclic compounds
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578414A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/28/2005EP1578341A2 Modulation of ccr4 function
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1341534A4 Compounds having fungicidal activity and processes to make and use same
09/28/2005EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/28/2005EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
09/28/2005EP1242397B1 Trans olefinic glucokinase activators
09/28/2005CN1675189A Novel use of benzothiazole derivatives
09/28/2005CN1675188A 噻唑衍生物 Thiazole derivatives
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1220687C Method for producing 2-cyanoimino-1, 3-thiazolidine
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949566 For use as metalloproteinase inhibitors
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949543 Amide derivative
09/27/2005US6949536 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005US6949516 Oligopeptides used as antiapoptosis agents
09/27/2005US6949259 Solid preparations for oral use
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005086904A2 Therapeutic modulation of ppar (gamma) activity
09/22/2005WO2005086661A2 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
09/22/2005WO2005086638A2 Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
09/22/2005WO2005072681A3 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209291 Amino benzothiazole compounds with NOS inhibitory activity
09/22/2005US20050209286 RXR activating molecules
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 337